z-logo
Premium
Adseverin plays a role in osteoclast differentiation and periodontal disease‐mediated bone loss
Author(s) -
Jiang Hongwei,
Wang Yongqiang,
Viniegra Ana,
Sima Corneliu,
McCulloch Christopher A.,
Glogauer Michael
Publication year - 2015
Publication title -
the faseb journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.709
H-Index - 277
eISSN - 1530-6860
pISSN - 0892-6638
DOI - 10.1096/fj.14-265744
Subject(s) - osteoclast , microbiology and biotechnology , podosome , bone resorption , actin , cytoskeleton , formins , gelsolin , resorption , chemistry , actin remodeling , actin cytoskeleton , biology , cell , biochemistry , genetics , endocrinology , in vitro
Osteoclast differentiation and function are highly dependent on the assembly and turnover of actin filaments, but little is known about the roles of actin binding proteins in these processes. Adseverin (Ads), a member of the gelsolin superfamily of actin capping and severing proteins, regulates actin filament turnover and can regulate the turnover of cortical actin filaments of chromaffin cells during exocytosis. Using a conditional Ads knockout mouse model, we confirmed our previous finding in cultured cells that Ads plays a role in osteoclastogenesis (OCG) and actin cytoskeletal organization in osteoclasts. Here we show that Ads is required for osteoclast formation and that when alveolar bone resorption is experimentally induced in mice, genetic deletion of Ads prevents osteoclast‐mediated bone loss. Further, when Ads‐null osteoclasts are cultured, they exhibit defective OCG, disorganized podosome‐based actin filament superstructures, and decreased bone resorption. Reintroduction of Ads into Ads‐null osteoclast precursor cells restored these osteoclast defects. Collectively, these data demonstrate a unique and osteoclast‐specific role for Ads in OCG and osteoclast function.— Jiang, H., Wang, Y., Viniegra, A., Sima, C., McCulloch, C. A., Glogauer, M. Adseverin plays a role in osteoclast differentiation and periodontal disease‐mediated bone loss. FASEB J. 29, 2281‐2291 (2015). www.fasebj.org

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here